Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Current Drug Metabolism|December 11, 2012
Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymesRamzi Shawahna, Xavier Decleves, Jean-Michel ScherrmannCurrent Neuropharmacology|May 6, 2017
Opioids and the Blood-Brain Barrier: A Dynamic Interaction with Consequences on Drug Disposition in BrainCatarina Chaves, Fernando Remiao, Salvatore Cisternino, et al.CPT: Pharmacometrics & Systems Pharmacology|May 15, 2024
Quantitative systems pharmacology modeling of tumor heterogeneity in response to BH3-mimetics using virtual tumors calibrated with cell viability assaysThibaud Derippe, Sylvain Fouliard, Xavier Decleves, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 28, 2013
Synthetic lipid nanoparticles targeting steroid organsJuliette Mérian, Raphaël Boisgard, Xavier Decleves, et al.Pharmaceutics|December 28, 2019
ABC Transporters at the Blood-Brain Interfaces, Their Study Models, and Drug Delivery Implications in GliomasDavid Gomez-Zepeda, Méryam Taghi, Jean-Michel Scherrmann, et al.Current Drug Metabolism|June 1, 2011
Interplay of drug metabolizing CYP450 enzymes and ABC transporters in the blood-brain barrierXavier Decleves, Aude Jacob, Salah Yousif, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 9, 2026
Shared and distinct effects of mood stabilizers on epigenetic machinery gene expression: an exploratory study in HeLa cellsVincent Hennion, Arthna Rathes, Alicja Puszkiel, et al.International Journal of Biological Macromolecules|June 14, 2021
Induced forms of α2-macroglobulin neutralize heparin and direct oral anticoagulant effectsGeorges Jourdi, Johan Abdoul, Virginie Siguret, et al.Molecular Pharmaceutics|November 10, 2012
Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier modelSumio Ohtsuki, Chiemi Ikeda, Yasuo Uchida, et al.Toxicology and Applied Pharmacology|March 14, 2023
Functional and targeted proteomics characterization of a human primary endothelial cell model of the blood-brain barrier (BBB) for drug permeability studiesDavid Gomez-Zepeda, Nicolas Perrière, Fabienne Glacial, et al.Pageof 2